OTLK
Price
$0.96
Change
+$0.02 (+2.13%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
42.68M
YDES
Price
$15.76
Change
+$0.19 (+1.22%)
Updated
Sep 8, 04:54 PM (EDT)
Capitalization
1.1B
Interact to see
Advertisement

OTLK vs YDES

Header iconOTLK vs YDES Comparison
Open Charts OTLK vs YDESBanner chart's image
Outlook Therapeutics
Price$0.96
Change+$0.02 (+2.13%)
Volume$4.09K
Capitalization42.68M
YD Bio
Price$15.76
Change+$0.19 (+1.22%)
Volume$298
Capitalization1.1B
OTLK vs YDES Comparison Chart in %
Loading...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YDES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OTLK vs. YDES commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTLK is a Hold and YDES is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (OTLK: $0.94 vs. YDES: $15.57)
Brand notoriety: OTLK and YDES are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OTLK: 113% vs. YDES: 133%
Market capitalization -- OTLK: $42.68M vs. YDES: $1.1B
OTLK [@Biotechnology] is valued at $42.68M. YDES’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OTLK’s FA Score shows that 1 FA rating(s) are green whileYDES’s FA Score has 0 green FA rating(s).

  • OTLK’s FA Score: 1 green, 4 red.
  • YDES’s FA Score: 0 green, 5 red.
According to our system of comparison, both OTLK and YDES are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OTLK’s TA Score shows that 5 TA indicator(s) are bullish while YDES’s TA Score has 5 bullish TA indicator(s).

  • OTLK’s TA Score: 5 bullish, 5 bearish.
  • YDES’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, YDES is a better buy in the short-term than OTLK.

Price Growth

OTLK (@Biotechnology) experienced а +9.84% price change this week, while YDES (@Biotechnology) price change was +24.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
YDES($1.1B) has a higher market cap than OTLK($42.7M). YDES YTD gains are higher at: 38.444 vs. OTLK (-50.529).
OTLKYDESOTLK / YDES
Capitalization42.7M1.1B4%
EBITDA-42.64MN/A-
Gain YTD-50.52938.444-131%
P/E Ratio0.59N/A-
Revenue1.51MN/A-
Total Cash8.9MN/A-
Total Debt34.7MN/A-
FUNDAMENTALS RATINGS
OTLK: Fundamental Ratings
OTLK
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OTLKYDES
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
10%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
15%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
13%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
19%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
22%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
13%
Declines
ODDS (%)
Bearish Trend 11 days ago
82%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
7%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YDES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MREO1.770.04
+2.31%
Mereo BioPharma Group plc
PDD124.680.81
+0.65%
PDD Holdings
BY28.93-0.25
-0.86%
Byline Bancorp
PB68.03-0.77
-1.12%
Prosperity Bancshares
FMST3.24-0.11
-3.28%
Foremost Clean Energy Ltd

OTLK and

Correlation & Price change

A.I.dvisor tells us that OTLK and MCRB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLK and MCRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
+5.27%
MCRB - OTLK
32%
Poorly correlated
+2.98%
VIR - OTLK
31%
Poorly correlated
+2.53%
ALEC - OTLK
30%
Poorly correlated
+6.74%
STRO - OTLK
30%
Poorly correlated
+3.92%
CRSP - OTLK
30%
Poorly correlated
+4.02%
More

YDES and

Correlation & Price change

A.I.dvisor tells us that YDES and OTLK have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YDES and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YDES
1D Price
Change %
YDES100%
+5.74%
OTLK - YDES
22%
Poorly correlated
+5.27%
JBIO - YDES
3%
Poorly correlated
-0.13%
LIMN - YDES
2%
Poorly correlated
-5.65%
IMA - YDES
2%
Poorly correlated
-5.80%
HIND - YDES
2%
Poorly correlated
+2.19%
More